The study for beneficial efficacy and safety of ezetimibe in patients with hyper LDL-cholesterolemia associated with diabetes mellitus (DM) including glucose intolerance and non-alcoholic fatty liver disease (NAFLD)

Trial Profile

The study for beneficial efficacy and safety of ezetimibe in patients with hyper LDL-cholesterolemia associated with diabetes mellitus (DM) including glucose intolerance and non-alcoholic fatty liver disease (NAFLD)

Completed
Phase of Trial: Phase II

Latest Information Update: 15 May 2014

At a glance

  • Drugs Ezetimibe (Primary)
  • Indications Hypercholesterolaemia
  • Focus Therapeutic Use
  • Most Recent Events

    • 28 Apr 2014 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan.
    • 04 Nov 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top